Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Biogen
Deal Size : $1,307.0 million
Deal Type : Collaboration
Details : As a part of the collaboration, Capsigen’s proprietary TRADE™ platform and associated technologies will be utilized with the aim to create and identify novel AAV capsids tailored to meet disease-specific transduction profiles.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : $15.0 million
October 05, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Biogen
Deal Size : $1,307.0 million
Deal Type : Collaboration